Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HRMYthis companyHarmony Biosciences Holdings, Inc.	$33.41	13.56×	2.47×	2.48×	6.42×	178.9%	77.2%	24.0%	18.3%	18.2%	13.9%	16.2%	0.28×	-2.01×	14.23×	3.6×	0.0%	5	5.63	4	A+
APAPMDApnimed, Inc.	$15.90	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
LBRXLB Pharmaceuticals Inc Common Stock	$43.40	-22.26×	1.87×	0×	-12.72×	-75.2%	0.0%	0.0%	0.0%	-8.4%	-9.9%	-6.3%	0.01×	9.91×	0×	41.44×	0.0%	2	25.27	2	C+
NERVMinerva Neurosciences, Inc.	$2.66	-0.12×	-0.24×	0×	-0.06×	-15.7%	0.0%	0.0%	0.0%	208.5%	-15.8%	-39708.5%	-0.46×	0.06×	0×	36.29×	0.0%	1	-24.23	2	C+
Peer median	—	-11.19×	0.81×	0×	-6.39×	-45.5%	0.0%	0.0%	0.0%	100.1%	-12.9%	-19857.4%	-0.22×	4.98×	0×	38.87×	0.0%	2	0.52	2	—